Cite
MLA Citation
Shakeel Modak et al.. “Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.” Pediatric blood & cancer, vol. 64, no. 8, 2017, p. n/a. http://access.bl.uk/ark:/81055/vdc_100047418214.0x00001d